-
Samsung Biologics to acquire Human Genome Sciences
23 Dec 2025 09:05 GMT
… Samsung Biologics America, to acquire Human Genome Sciences from GSK as part of …
-
Human Genome Sciences Soon to Be Part of Samsung Biologics
23 Dec 2025 00:27 GMT
… a definitive agreement to acquire Human Genome Sciences from GSK. The move secures …
-
Korea's Samsung Biologics expands US manufacturing capabilities after acquiring Human Genome Sciences from GSK
22 Dec 2025 10:11 GMT
… US manufacturing capabilities after acquiring Human Genome Sciences from GSK
December 22, 2025 … agreement to acquire 100% of Human Genome Sciences from GSK. This strategic move …
-
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
21 Dec 2025 23:49 GMT
… agreement to acquire 100% of Human Genome Sciences from GSK (LSE/NYSE … -capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk-302647637.html
SOURCE …
-
Samsung Biologics reports 30% revenue growth in 2025 driven by plant utilization
23 Jan 2026 20:10 GMT
… company announced it is acquiring Human Genome Sciences’ biologics manufacturing site in Rockville …
-
Next Generation Sequencing Market Size to Worth USD 103.24 Bn by 2035
22 Jan 2026 03:35 GMT
… States, acquiring the plant of Human Genome Sciences from global drug giant GSK …
-
Biotechnology Market Size to Surpass USD 9.06 Trillion by 2035
20 Jan 2026 11:52 GMT
… States, acquiring the plant of Human Genome Sciences from global drug giant GSK …
-
MCPS Will Redraw Boundaries – Hopefully Along the Great Seneca Science Corridor (Opinion)
19 Jan 2026 16:43 GMT
… Biologics, which acquired the former Human Genome Sciences facility in Rockville, announced expansion …
-
Samsung Biologics Weighs Sixth Korea Plant, U.S. Expansion
14 Jan 2026 14:38 GMT
… .
The acquisition, formerly operated by Human Genome Sciences, is intended to strengthen Samsung …
-
Samsung Biologics mulls expansion of plants, portfolios for growth
14 Jan 2026 01:06 GMT
… in Rockville, formerly operated by Human Genome Sciences, from British multinational pharmaceutical firm …